ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 407 filers reported holding ENCOMPASS HEALTH CORP in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,412,833 | -49.7% | 36,608 | -48.7% | 0.00% | -42.9% |
| Q2 2023 | $4,794,980 | +126.9% | 71,407 | +82.8% | 0.01% | +133.3% |
| Q1 2023 | $2,113,687 | +26.5% | 39,070 | +39.8% | 0.00% | 0.0% |
| Q4 2022 | $1,671,032 | +390.0% | 27,939 | +270.4% | 0.00% | +200.0% |
| Q3 2022 | $341,000 | +18.0% | 7,543 | +16.4% | 0.00% | – |
| Q2 2022 | $289,000 | -65.4% | 6,482 | -49.3% | 0.00% | -100.0% |
| Q4 2021 | $835,000 | -35.6% | 12,792 | -25.9% | 0.00% | -50.0% |
| Q3 2021 | $1,296,000 | +468.4% | 17,274 | +491.2% | 0.00% | – |
| Q2 2021 | $228,000 | -7.3% | 2,922 | -2.9% | 0.00% | – |
| Q1 2021 | $246,000 | +8.8% | 3,009 | +9.9% | 0.00% | – |
| Q4 2020 | $226,000 | -83.2% | 2,737 | -88.1% | 0.00% | -100.0% |
| Q1 2019 | $1,344,000 | +23.9% | 23,015 | +30.9% | 0.00% | 0.0% |
| Q4 2018 | $1,085,000 | +386.5% | 17,577 | +514.2% | 0.00% | +200.0% |
| Q3 2018 | $223,000 | – | 2,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |